Schizophrenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for schizophrenia according to DSM-5; 2. Aged 18–45 years; 3. Years of education >= 6 years; 4. First-episode, total duration of illness <= 5 years; 5. Previous systematic use of antipsychotics, antidepressants, mood stabilizers, or other psychotropic medications for a total duration <= 2 weeks; 6. Right-handed; normal vision and hearing (or corrected to normal), no color weakness or color blindness, no communication impairments; 7. Legal guardians and/or patients voluntarily participate in the study and sign the informed consent form;
Exclusion criteria
Exclusion criteria: 1. Comorbid with mental retardation or other organic brain diseases, with IQ below 85; 2. Severe decline or impulsive excitement and uncooperative; 3. Comorbid with severe depression, anxiety, and substance abuse (except tobacco); 4. Presence of organic auditory and/or visual perceptual impairments; 5. Unstable condition, severe physical illness, or severe medication side effects (e.g., severe extrapyramidal symptoms, tardive dyskinesia, etc.); 6. Use of immunomodulators, neurotrophic agents, antioxidants, etc. within the past 8 weeks; 7. Pregnant or lactating women; 8. Infectious diseases occurring within the past 2 weeks; 9. Receipt of physical neuromodulation treatments such as tDCS, tACS, TMS, or modified electroconvulsive therapy within the past 6 months;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| social attention effect; | — |
Countries
China
Contacts
Beijing HuiLongGuan Hospital